Major Decline in KOSPI 200 as Samsung Biologics Leads the Downtrend
Seoul: The KOSPI 200 index faced a significant downturn with several major stocks experiencing declines in their closing prices. The session saw Samsung Biologics leading
Seoul: The KOSPI 200 index faced a significant downturn with several major stocks experiencing declines in their closing prices. The session saw Samsung Biologics leading
Seoul: The KOSPI 200 index faced a significant downturn with several major stocks experiencing declines in their closing prices. The session saw Samsung Biologics leading
Seoul: Loans extended to companies in South Korea grew at a slower pace in the fourth quarter compared with the previous quarter amid sluggish demand
Seoul: Loans extended to companies in South Korea grew at a slower pace in the fourth quarter compared with the previous quarter amid sluggish demand
Seoul: The South Korean won depreciated sharply against the U.S. dollar Monday, hitting its lowest point since the 2008 global financial crisis, as oil prices
Seoul: The South Korean won depreciated sharply against the U.S. dollar Monday, hitting its lowest point since the 2008 global financial crisis, as oil prices